Institutional Ownership Xilio Therapeutics, Inc. (XLO)
This table provides information about the institutional ownership of Xilio Therapeutics, Inc. (XLO). We have compiled data on the 34 institutions that hold shares in the stock, with a total of 11.1 Million shares, which have been reported (via 13F filing form) to have a value of $10.2 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Bain Capital Life Sciences Investors, LLC
Boston, MA |
May 15, 2025 Q1 2025 |
4,566,817
shares
|
$4.2 Million
1.1% of portfolio
|
Q3 2024
Added 20.64%
|
|
River Vest Venture Management LLC
St. Louis, MO |
Oct 30, 2024 Q3 2024 |
1,441,444
shares
|
$1.33 Million
16.6% of portfolio
|
Q4 2021
New holding
|
|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
1,155,838
shares
|
$1.06 Million
0.0% of portfolio
|
Q1 2025
Added 15.43%
|
|
Vanguard Group Inc
Valley Forge, PA |
May 09, 2025 Q1 2025 |
1,135,716
shares
|
$1.04 Million
0.0% of portfolio
|
Q1 2025
Added 25.84%
|
|
Aju Ib Investment Co., Ltd.
Seoul, M5 |
Apr 08, 2025 Q1 2025 |
667,742
shares
|
$614,322
0.57% of portfolio
|
Q4 2021
New holding
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2025 Q1 2025 |
379,016
shares
|
$348,694
0.0% of portfolio
|
Q1 2025
Added 5.75%
|
|
Balyasny Asset Management LLC
Chicago, IL |
May 15, 2025 Q1 2025 |
254,346
shares
|
$233,998
0.0% of portfolio
|
Q1 2025
Reduced 25.9%
|
|
Trustees Of Columbia University In The City Of New York
New York, NY |
May 15, 2025 Q1 2025 |
249,635
shares
|
$229,664
0.03% of portfolio
|
Q4 2022
New holding
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
May 14, 2025 Q1 2025 |
177,700
shares
|
$163,484
0.0% of portfolio
|
Q1 2025
Reduced 40.09%
|
|
Ubs Group Ag
|
May 13, 2025 Q1 2025 |
163,101
shares
|
$150,052
0.0% of portfolio
|
Q1 2025
Reduced 34.6%
|
|
Avantax Planning Partners, Inc.
|
Apr 28, 2025 Q1 2025 |
150,399
shares
|
$138,367
0.0% of portfolio
|
Q1 2025
New holding
|
|
Two Sigma Investments, LP
New York, NY |
May 15, 2025 Q1 2025 |
84,068
shares
|
$77,342
0.0% of portfolio
|
Q1 2025
Added 676.68%
|
|
Bridgeway Capital Management, LLC
Houston, TX |
May 15, 2025 Q1 2025 |
71,081
shares
|
$65,394
0.0% of portfolio
|
Q1 2024
Reduced 54.28%
|
|
Northern Trust Corp
Chicago, IL |
May 13, 2025 Q1 2025 |
66,609
shares
|
$61,280
0.0% of portfolio
|
Q1 2025
Added 69.89%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
66,418
shares
|
$61,104
0.0% of portfolio
|
Q2 2024
Added 46.44%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
May 15, 2025 Q1 2025 |
51,110
shares
|
$47,021
0.0% of portfolio
|
Q1 2025
New holding
|
|
Aptus Capital Advisors, LLC
|
May 13, 2025 Q1 2025 |
46,000
shares
|
$42,320
0.0% of portfolio
|
Q1 2025
Added 12.2%
|
|
Seven Bridge Financial Group, LLC
|
May 13, 2025 Q1 2025 |
46,000
shares
|
$42,320
0.01% of portfolio
|
Q1 2025
Added 12.2%
|
|
State Street Corp
Boston, MA |
May 15, 2025 Q1 2025 |
43,390
shares
|
$39,918
0.0% of portfolio
|
Q2 2024
Added 176.55%
|
|
Scientech Research LLC
Jersey City, NJ |
May 15, 2025 Q1 2025 |
42,546
shares
|
$39,142
0.01% of portfolio
|
Q1 2025
New holding
|
|
Adar1 Capital Management, LLC
Austin, TX |
May 15, 2025 Q1 2025 |
40,000
shares
|
$36,800
0.01% of portfolio
|
Q1 2025
New holding
|
|
Raymond James & Associates
St Petersburg, FL |
Oct 18, 2024 Q3 2024 |
38,825
shares
|
$35,719
0.0% of portfolio
|
Q2 2024
New holding
|
|
Raymond James Financial Inc
St. Petersburg, FL |
May 13, 2025 Q1 2025 |
33,961
shares
|
$31,244
0.0% of portfolio
|
Q1 2025
Reduced 32.19%
|
|
Mariner, LLC
Overland Park, KS |
May 15, 2025 Q1 2025 |
25,000
shares
|
$23,000
0.0% of portfolio
|
Q4 2024
Reduced 1.25%
|
|
Steward Partners Investment Advisory, LLC
|
May 13, 2025 Q1 2025 |
20,000
shares
|
$18,400
0.0% of portfolio
|
Q3 2024
New holding
|